Adaptive Biotechnologies Corp at JPMorgan Healthcare Conference Transcript
&-
Perfect. Good afternoon, everyone. This is Rachel Vatnsdal with the life science tools and diagnostics team at JP Morgan. I'm joined by the Adaptive team up here on stage.
And this is going to be a 40-minute session, roughly 20, 25 minutes of presentation, followed by Q&A. If any of you in the room have questions, feel free to either submit them via the app or you can ping me directly. With that, I will pass it up to Chad.
Awesome. Thank you, Rachel. Appreciate the opportunity to present once again at JP Morgan. I want to wish you Happy New Year and welcome everyone in the room and those of you who are also listening by webcast. For those of you who are new to the company, Adaptive's mission is to translate the genetics of the adaptive immune system to create clinical products to both detect and treat disease.
Throughout the last decade, we pioneered two exciting
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |